INNV
NASDAQ
US
InnovAge Holding Corp. - Common Stock
$7.61
▼ $-0.41
(-5.11%)
Vol 277K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$704.2M
ROE
-7.2%
Margin
-2.0%
D/E
28.79
Beta
0.54
52W
$3–$6
Wall Street Consensus
9 analysts · Apr 20260
Strong Buy
0
Buy
5
Hold
2
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
ADUS
Addus Homecare Corp
P/E 23.2
$2.0B
AVAH
Aveanna Healthcare Holdings Inc
P/E 22.6
$1.7B
ASTH
Astrana Health Inc
P/E 130.5
$1.2B
NEO
Neogenomics Inc
$1.5B
PNTG
Pennant Group Inc
P/E 36.5
$973.8M
LMRI
Lumexa Imaging Holdings Inc
TALK
Talkspace Inc
P/E 141.8
$601.3M
OPK
OPKO Health Inc
$967.3M
OMDA
Omada Health Inc
$913.8M
CSTL
Castle Biosciences Inc
$1.1B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.04 | $0.08 | +$0.04 |
| Sep 2025 | $0.01 | $0.06 | +$0.05 |
| Jun 2025 | $-0.02 | $-0.01 | +$0.01 |
| Mar 2025 | $-0.01 | $-0.08 | $-0.07 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $209.0M | $218.1M | $221.4M | $236.1M | $239.7M |
| Net Income | -$13.2M | -$11.4M | -$785K | $8.0M | $10.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -12.3% | -12.3% | -12.3% | -12.3% | -7.2% | -7.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -0.3% | -3.8% | -3.5% | -3.5% | -2.0% | -2.0% |
| Gross Margin | 18.6% | 17.9% | 18.0% | 18.0% | 19.3% | 19.3% |
| D/E Ratio | 30.85 | 32.33 | 30.85 | 30.85 | 28.79 | 28.79 |
| Current Ratio | 1.07 | 0.78 | 1.07 | 1.07 | 1.17 | 1.17 |
Key Ratios
ROA (TTM)
-3.3%
P/S (TTM)
0.80
P/B
2.1
EPS (TTM)
$-0.13
CF/Share
$-0.18
Rev Growth 3Y
+6.9%
52W High
$6.26
52W Low
$2.60
$2.60
52-Week Range
$6.26
Financial Health
Free Cash Flow
$19.0M
Net Debt
$12.2M
Cash
$83.2M
Total Debt
$95.4M
As of Dec 31, 2025
How does INNV compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
INNV valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.8
▼
69%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
2.1
▼
24%
below
peers
(2.8)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
INNV profitability vs Health Care peers
ROE
-7.2%
▲
81%
above
peers
(-38.5%)
vs Peers
vs Industry
Below avg
Net margin
-2.0%
▲
92%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
19.3%
▼
64%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-3.3%
▲
84%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
INNV financial health vs Health Care peers
D/E ratio
28.8
▲
49%
above
peers
(19.3)
vs Peers
vs Industry
Above avg
Current ratio
1.2
▼
46%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
48%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
INNV fundamentals radar
INNV
Peer median
Industry
INNV profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INNV vs peers: key metrics
Top Holders
Top 5: 8.92%T. Rowe Price Investment Ma…
4.55%
$48.1M
Coliseum Capital Management…
2.19%
$23.2M
Blackrock Inc.
0.93%
$9.8M
Vanguard Group Inc
0.84%
$8.9M
Geode Capital Management, L…
0.41%
$4.3M
As of Dec 31, 2025
Latest News
No related news yet